Sharp Therapeutics Company Description

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a proprietary IP-protected analytics platform that captures all data for all AlloChem compounds in all CoreX assays.

Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania.

Sharp Therapeutics Corp.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Scott Sneddon

Contact Details

Address: 2403 Sidney Street Pittsburgh, Ontario 15203 United States
Phone	412 206 5303
Website	sharptx.com

Stock Details

Ticker Symbol	SHRX
Exchange	TSX Venture Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	8731

Key Executives

Name	Position
Dr. Scott F. Sneddon J.D., Ph.D.	Chief Executive Officer, Chief Science Officer and Director
Edward Jonasson CA CPA	Chief Financial Officer
Lorne Michael Sugarman	Independent Director and Corporate Secretary
Marcel P. Bruchez Ph.D.	Scientific Co-Founder and Chief Technology Officer
Dr. Alan S. Waggoner Ph.D.	Scientific Co-Founder and Chief Architect